ArticleRespiratory medicine case reports2026
A case of marginal zone lymphoma presenting with paraneoplastic vasculitis and pulmonary infiltration.
Article in Respiratory medicine case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Paraneoplastic vasculitis is a rare but important manifestation of underlying malignancies, most commonly hematological, and often presents with atypical features resistant to standard immunosuppression. Marginal zone lymphoma (MZL), a low-grade B-cell lymphoma, may infrequently present with pulmonary involvement and paraneoplastic immune phenomena. Case description: We report a 73-year-old male with a history of COPD who presented with progressive dyspnoea, weight loss, lower limb purpura, and pancytopenia. Initial suspicion included pneumonia and COPD exacerbation; however, imaging revealed bilateral pulmonary infiltrates and pleural effusion. Laboratory evaluation showed systemic inflammation and worsening cytopenias. Further workup, including PET-CT and biopsies, identified CD20-positive extranodal marginal zone lymphoma with pulmonary infiltration. The patient developed presumed paraneoplastic vasculitis involving the skin and coronary arteries, in the absence of classical autoimmune markers. Rituximab monotherapy was initiated, resulting in both clinical and radiological improvement. Conclusions: This case highlights the importance of considering underlying malignancy in patients with unexplained systemic inflammation, vasculitic skin lesions, or cytopenias, particularly when autoimmune markers are negative. Prompt histological diagnosis and multidisciplinary collaboration enabled timely immunochemotherapy, resulting in the resolution of both lymphoma and associated paraneoplastic complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.